A Clinical Trial Data Review Workflow for Small Research Teams
A practical workflow for reviewing study health, incomplete records, role changes, audit events, and exports before clinical research analysis.
Trialinx
Trialinx editorial team
A Clinical Trial Data Review Workflow for Small Research Teams
A small research team can review clinical trial data without creating a large meeting ritual. The team needs a defined sequence: check study status, inspect incomplete records, review changes, resolve access questions, and test the export before analysis. Each step should leave a clear reason for the decision and a person responsible for the next action.
Trialinx gives teams the building blocks for that workflow. Study health exposes enrollment, arm counts, form completion, and outstanding draft records. Role-based permissions separate viewing from editing and management. The audit trail records actions such as updates, exports, role changes, signatures, and imports with the user, study, entity, request context, and changed values. A review process turns those product capabilities into a repeatable operating habit.
Start with a review question
Data review becomes slow when the team opens a study without deciding what it wants to learn. Start each review with one question and one scope.
Examples:
- Which subjects have a required form still in draft?
- Which records changed after the last review?
- Which users exported data or changed a study role?
- Does the analysis export preserve the visit and form identifiers?
Write the question in the review note or meeting record. Then select the relevant study, date range, site, form, or subject scope. A narrow scope helps the reviewer distinguish a real exception from normal study activity.
Use study health to choose the first queue
The first pass should identify work that can change the study’s operational picture. Trialinx study health includes enrollment totals, optional recruitment targets, randomization-arm counts, submitted and total form records, completion percentage, and outstanding draft records.
Use those values to build a short review queue:
1. Find the subjects or visits with incomplete records.
2. Check whether the missing record reflects an expected future visit, a missed visit, or an unfinished form.
3. Assign the follow-up to the person who can resolve it.
4. Record the outcome instead of changing a value to make the dashboard look complete.
A completion percentage cannot explain why a record remains outstanding. The coordinator still needs the form, subject, and visit context. The number helps the team locate the queue; it does not replace the review.
For longitudinal studies, inspect completion by visit. A subject may have a complete baseline record and an outstanding follow-up. A study-level total can hide that difference. Repeatable forms and visit instances give the team a way to keep that time context visible.
Match permissions to the review task
Review work needs a clear boundary between seeing data and changing it. Trialinx defines four study roles: viewer, collaborator, manager, and owner. The repository’s role model gives each role a different position in the permission hierarchy, and the server checks permissions on API requests.
Use the least powerful role that can complete the assigned task:
- A viewer can inspect study information without becoming a data editor.
- A collaborator can work with study data when the study grants that access.
- A manager can handle broader study administration and review actions.
- An owner controls the study and its membership decisions.
The exact permission matrix belongs in the study’s operating procedure. A team should record which role owns each review decision, who can correct a record, and who approves an export. Avoid sharing an owner account to save time. Shared credentials erase the person-level context that the audit trail needs.
Review access at the start of a study and after a role change. Remove access when a person no longer needs it. The audit trail can show that a role changed, but the team still needs a routine for deciding whether the change was expected.
Review records before reviewing trends
The team should inspect the record before it interprets the number.
For each item in the review queue, check:
- Subject and study identifiers
- Form name and version context
- Visit or collection date, when applicable
- Required fields and validation messages
- Draft or submitted state
- Any correction reason or source-data note required by the protocol
This sequence helps the reviewer separate an incomplete form from a completed form with an unusual value. It also limits the risk of treating an entry problem as a clinical finding.
Trialinx forms support field-level rules such as required fields, ranges, conditional visibility, and calculated fields. Those rules can prevent common entry mistakes, but they cannot determine whether a surprising observation is clinically plausible. The reviewer must decide whether to confirm the value, query the source, or document a protocol-specific exception.
For a repeated form, review the subject’s visit sequence as well as the current record. Check whether the visit label matches the protocol and whether the team entered the measurement on the expected visit. Keep the original observation visible when the team corrects a data-entry mistake. The review history should explain what changed and why.
Use the audit trail to review changes
An audit trail becomes useful when the team asks a focused question. Trialinx supports audit actions for create, update, delete, publish, archive, invite, member removal, role change, signing, export, and import. Each log entry can include the user ID, study ID, entity type and ID, IP address, user agent, timestamp, and old or new values.
Review changes in two passes.
Pass one: find activity that needs context
Filter the review period by study, user, or entity. Look for updates to form definitions, subjects, form records, dashboards, and study membership. Pay attention to changes made after a data cut, analysis freeze, or team handoff.
The event tells you what happened. It may not tell you whether the action followed the protocol. Ask the person responsible for the action to add the operational explanation in the study’s review record or query process.
Pass two: compare the before and after values
Use the old and new values to confirm the change. Check whether the correction fixed a transcription error, completed a missing value, changed a form definition, or altered a permission. If the values do not explain the change, inspect the surrounding record and ask for the source document or decision note required by the study.
Do not treat an audit event as proof that the underlying data are correct. The event proves that the system recorded an action. The research team still evaluates the reason and the effect on the analysis set.
The FDA guidance on electronic source data connects traceability with clear data-element identifiers, source-data capture, review, and retention. A product audit trail supports that work. The study team supplies the procedure, training, and review decisions.
Review exports as a separate control
An export can look complete while losing the context needed to interpret a record. Test the file with a small, known set of records before the team relies on it for analysis.
Confirm that the export keeps:
- Subject identifiers in the format approved for the study
- Form identifiers or unambiguous form names
- Visit instance identifiers for repeated forms
- Field values, units, and collection dates
- Record state and relevant review notes
Trialinx documents JSON data export for user-related data, including studies, form records, dashboards, and signature events. That export serves a portability need. An analysis export may require a different shape, so the statistician or data manager should document any transformation before using it.
Keep the raw export unchanged. Create a separate analysis file when you need to reshape repeated records, derive variables, or select a population. Record the source export, transformation date, and person who approved the analysis file. The team can then trace a reported value back to the source record without asking someone to reconstruct the steps from memory.
Close the review with decisions
The review is complete when the team knows what happens next. Close each queue item with one of four decisions:
- No action required. The record matches the protocol and data plan.
- Correction required. The owner assigns a specific record change.
- Source or clinical query required. The team requests evidence or expert review.
- Protocol or process issue. The manager updates the workflow, training, or review plan.
Name the person responsible and the due date. When the team resolves the item, record the resolution and check the resulting audit event. A short decision record gives the next reviewer context without forcing them to repeat the investigation.
The same pattern works for role changes and exports. A manager can record why access changed, who approved the export, and where the team stored the review record. The software provides the event; the operating procedure provides the meaning.
A weekly workflow for a small team
Small teams can run this review once per week, or more often around a data cut:
1. The study owner states the review question and scope.
2. The coordinator checks study health and builds the incomplete-record queue.
3. The data reviewer checks records, visits, validations, and outstanding questions.
4. The manager reviews changes, role events, exports, and unresolved exceptions.
5. The team closes decisions, assigns follow-up, and records the next review date.
Keep the meeting short by moving detailed investigations into assigned items. Link each item to the study, subject, form, visit, or audit event that triggered it. That structure lets a new reviewer pick up the queue without starting from the dashboard summary.
The guide on setting up a clinical trial database covers the design work that makes this review possible: data dictionaries, form structure, validation, roles, exports, and a pilot before enrollment. The AI-assisted statistical analysis guide covers the next boundary. AI can help prepare tables and surface questions, while the research team reviews assumptions and accepts the interpretation.
Keep reviewable data reviewable
A data review workflow should reduce uncertainty at each step. Study health shows where work remains. Roles identify who can act. The audit trail records the action and its context. A tested export preserves the identifiers that connect the analysis back to the study.
Trialinx gives small research teams those pieces in one study environment. The team still sets the protocol, trains reviewers, protects confidentiality, and decides what the evidence supports. Start with one review question, run it on one study, and record the decisions that the next reviewer will need.
Explore Trialinx’s clinical research features or request a demo if you want to test this workflow with your own study structure.
Sources
Want to try Trialinx?
Free plan with 1 study, 15 forms, and 10 subjects. No credit card.
Related articles
How to Model Longitudinal Clinical Research Data with Repeatable Forms
A practical guide to visit instances, repeatable forms, completion tracking, validation, and export structure for longitudinal clinical research data.
AI-Assisted Statistical Analysis for Small Clinical Teams
A practical guide to using AI for reviewable statistical analysis in small clinical research teams without handing over methodological judgment.
Electronic Signatures in Clinical Trials: 21 CFR Part 11 Explained
A practical guide to electronic signatures in clinical trials and 21 CFR Part 11, covering signer identity, timestamps, signature meaning, record linking, audit trails, SOPs, and Trialinx signature-event evidence.